Product Information

Open The Door To Market For Women's Health Products And Successfully Create Many Well-Known Star Brands

undefined
+
  • undefined

Fluticasone Propionate Nebuliser Suspension


Generic Name:

Fluticasone Propionate Nebuliser Suspension

Indications:

Treatment of mild to moderate acute asthma exacerbations in children and adolescents aged 4 to 16 years.

Fluticasone propionate has significant anti-inflammatory effects in the lungs.

In patients with asthma who previously only received bronchodilator therapy or other prophylactic treatments, fluticasone propionate can reduce asthma symptoms and acute exacerbations.

While quick-relief bronchodilators can generally alleviate relatively short-lived acute exacerbation symptoms, longer-lasting acute exacerbations require prompt treatment with corticosteroids to control inflammation.

Dosage forms and strengths: Inhalation suspension: 0.5 mg/2 mL

  • Description
  • Generic Name: Fluticasone Propionate Nebuliser Suspension

    Indications: Treatment of mild to moderate acute asthma exacerbations in children and adolescents aged 4 to 16 years.

    Fluticasone propionate has significant anti-inflammatory effects in the lungs.

    In patients with asthma who previously only received bronchodilator therapy or other prophylactic treatments, fluticasone propionate can reduce asthma symptoms and acute exacerbations.

    While quick-relief bronchodilators can generally alleviate relatively short-lived acute exacerbation symptoms, longer-lasting acute exacerbations require prompt treatment with corticosteroids to control inflammation.

    Dosage forms and strengths: Inhalation suspension: 0.5 mg/2 mL

    Dosage and administration:

    Treatment of acute asthma exacerbations in children and adolescents aged 4 to 16 years: 1 mg, twice daily.

    The initial dose of nebulized fluticasone propionate should be administered based on the severity of the child's condition. Then, adjust the dose according to individual response until the condition is controlled or reduced to the minimum effective dose.

    When treating acute asthma exacerbations, it is recommended to use the maximum dose within this range, up to 7 days following the exacerbation. Subsequently, consideration should be given to reducing the dose.